reserpine has been researched along with carbostyril in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Eigyo, M; Kawasaki, K; Matsubara, K; Matsushita, A; Shindo, H; Takada, S | 1 |
| Bielecka, Z; Chojnacka-Wójcik, E; Dereń-Wesołek, A; Kłodzińska, A; Maćkowiak, M; Mokrosz, JL; Paluchowska, MH | 1 |
| Hirose, T; Kikuchi, T; Miwa, T; Morita, S; Oshiro, Y; Tottori, K; Uwahodo, Y | 1 |
| Domae, M; Furukawa, T; Inoue, T; Yamada, K | 1 |
| Borea, PA; Dorigo, P; Floreani, M; Fraccarollo, D; Gaion, RM; Maragno, I; Mosti, L; Santostasi, G | 1 |
| Konieczny, J; Lorenc-Koci, E; Ossowska, K; Wolfarth, S | 1 |
| Duan, DQ; Lin, YG; Xu, F | 1 |
| Avrain, L; Garvey, M; Glupczynski, Y; Mesaros, N; Mingeot-Leclercq, MP; Piddock, LJ; Tulkens, PM; Van Bambeke, F; Vanhoof, R | 1 |
| Adham, N; Agai-Csongor, E; Bugovics, G; Domány, G; Fazekas, K; Gyertyán, I; Hornok, K; Horváth, A; Kiss, B; Laszlovszky, I; Némethy, Z; Orosz, S; Schmidt, E; Szombathelyi, Z; Tihanyi, K | 1 |
| Carlsson, A; Carlsson, ML; Johansson, AM; Rung, E; Rung, JP; Svensson, K | 1 |
| Gründer, G; Gur, R; Hiemke, C; Schiffl, K; Schorn, H; Vernaleken, I; Veselinović, T; Zernig, G | 1 |
| Gründer, G; Gur, R; Hiemke, C; Schorn, H; Vernaleken, IB; Veselinovic, T; Zernig, G | 1 |
| Cantón, R; Gargallo-Viola, D; López, Y; Tato, M; Vila, J; Zsolt, I | 1 |
2 trial(s) available for reserpine and carbostyril
| Article | Year |
|---|---|
Effects of antipsychotic treatment on psychopathology and motor symptoms. A placebo-controlled study in healthy volunteers.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Dopamine; Female; Haloperidol; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Quinolones; Reserpine; Single-Blind Method; Young Adult | 2011 |
Effects of antipsychotic treatment on cognition in healthy subjects.
Topics: Adrenergic Uptake Inhibitors; Adult; Antipsychotic Agents; Aripiprazole; Attention; Brain; Cognition; Cognition Disorders; Dopamine Antagonists; Female; Haloperidol; Humans; Learning; Male; Middle Aged; Neurons; Piperazines; Quinolones; Reaction Time; Reserpine; Single-Blind Method; Young Adult | 2013 |
11 other study(ies) available for reserpine and carbostyril
| Article | Year |
|---|---|
Activation of brain function by S-135, a benzodiazepine receptor inverse agonist.
Topics: Animals; Antidepressive Agents; Avoidance Learning; Brain; Cerebral Cortex; Deoxyglucose; Depression; Disease Models, Animal; Isometric Contraction; Male; Mice; Mice, Inbred Strains; Motor Activity; Muscle Contraction; Muscles; Pyrazoles; Quinolones; Rats; Rats, Inbred Strains; Receptors, GABA-A; Reflex; Reserpine; Seizures; Synaptosomes | 1988 |
Structure-activity relationship studies of CNS agents. XII. 1-[4-(4-aryl-1-piperazinyl)butyl]-3,4-dihydro-2(1H)-quinolinones: new 5-HT1A, 5-HT2 and D2 ligands with a potential antipsychotic activity.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Behavior, Animal; Central Nervous System Stimulants; Dextroamphetamine; Dopamine D2 Receptor Antagonists; In Vitro Techniques; Male; Motor Activity; Quinolones; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Dopamine D1; Reserpine; Serotonin Antagonists; Tryptamines | 1994 |
7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity.
Topics: 4-Butyrolactone; Animals; Antipsychotic Agents; Apomorphine; Aripiprazole; Catalepsy; Corpus Striatum; Dihydroxyphenylalanine; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Male; Mice; Mice, Inbred ICR; Motor Activity; Oxidopamine; Piperazines; Presynaptic Terminals; Quinolones; Radioligand Assay; Rats; Reserpine; Spiperone; Stereotyped Behavior; Synapses; Tritium | 1995 |
Effects of the novel antipsychotic agent 7-(4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro -2(1H)-quinolinone (OPC-14597) on prolactin release from the rat anterior pituitary gland.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Azepines; Estradiol; Haloperidol; In Vitro Techniques; Male; Piperazines; Pituitary Gland, Anterior; Prolactin; Quinolones; Rats; Rats, Wistar; Receptors, Dopamine D2; Reserpine | 1996 |
New inotropic agents: milrinone analogs.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine; Adenosine Deaminase; Animals; Atrial Function; Binding, Competitive; Cardiotonic Agents; Cyclic Nucleotide Phosphodiesterases, Type 3; Electric Stimulation; Guinea Pigs; Heart Atria; In Vitro Techniques; Male; Milrinone; Myocardial Contraction; Myocardium; Phenylisopropyladenosine; Phosphodiesterase Inhibitors; Propranolol; Pyridones; Quinolones; Receptors, Adrenergic, beta; Receptors, Purinergic P1; Reserpine | 1997 |
The role of striatal glutamate receptors in models of Parkinson's disease.
Topics: Animals; Corpus Striatum; Disease Models, Animal; Dizocilpine Maleate; Electromyography; Excitatory Amino Acid Antagonists; Haloperidol; Kynurenic Acid; Parkinson Disease; Quinolones; Rats; Receptors, N-Methyl-D-Aspartate; Reserpine | 1998 |
[A study on the active efflux mechanism in Staphylococcus aureus resistant to quinolone].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Quinolones; Reserpine; Staphylococcus aureus | 2004 |
Selection of quinolone resistance in Streptococcus pneumoniae exposed in vitro to subinhibitory drug concentrations.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Microbial Sensitivity Tests; Mutation; Quinolones; Reserpine; Selection, Genetic; Streptococcus pneumoniae; Time Factors | 2007 |
Cariprazine (RGH-188), a dopamine D(3) receptor-preferring, D(3)/D(2) dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile.
Topics: 4-Butyrolactone; Animals; Antipsychotic Agents; Aripiprazole; Brain; Cell Line; Cricetinae; Cricetulus; Cyclic AMP; Dopamine; Dopamine D2 Receptor Antagonists; Drug Partial Agonism; Guinea Pigs; Humans; In Vitro Techniques; Inositol Phosphates; Male; Mice; Piperazines; Quinolones; Radioligand Assay; Rats; Receptors, Dopamine D3; Receptors, Histamine H1; Receptors, Serotonin; Recombinant Proteins; Reserpine; Serotonin | 2010 |
Effects of the dopamine stabilizers (S)-(-)-OSU6162 and ACR16 on prolactin secretion in drug-naive and monoamine-depleted rats.
Topics: Animals; Aripiprazole; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; Hyperprolactinemia; Lactotrophs; Male; Methyltyrosines; Piperazines; Piperidines; Prolactin; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Reserpine | 2011 |
Comparative activity of ozenoxacin and other quinolones in Staphylococcus aureus strains overexpressing the efflux pump-encoding genes mepA and norA.
Topics: Aminopyridines; Anti-Bacterial Agents; Bacterial Proteins; Endopeptidases; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Quinolones; Reserpine; Staphylococcus aureus | 2020 |